Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) , and immune responses. A significant impediment to enhancing the efficacy of brain tumor
treatment lies
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) methods frequently fall short, underscoring the imperative for non-invasive alternatives. Non-coding RNAs
Beylerli, Ozal,
Encarnacion Ramirez, Manuel de Jesus,
Shumadalova, Alina,
Ilyasova, Tatiana,
Zemlyanskiy, Mikhail,
Beilerli, Aferin,
Montemurro, Nicola (2023) , or brain metastasis, presents a considerable obstacle, while current
treatment methods often yield
Beylerli, Ozal,
Tamrazov, Rasim,
Gareev, Ilgiz,
Ilyasova, Tatiana,
Shumadalova, Alina,
Bai, Yunlong,
Yang, Baofeng (2023) in understanding the pathophysiology of TBI, effective
treatments remain limited. In recent years, exosomal non
Xu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) and dural inversion synangiosis for the
treatment of moyamoya disease in adults.
Methods: Patients treated
Mukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) at the stages of surgical
treatment (the nearest post-traumatic period and long-term periods) in the absence
Beylerli, Ozal,
Gareev, Ilgiz,
Beilerli, Aferin,
Ilyasova, Tatiana,
Shi, Huaizhang,
Sufianov, Albert (2024) , exploring corresponding
treatment strategies that capitalize on these insights. © 2024 Elsevier B.V.
Wang, Chunlei,
Beylerli, Ozal,
Gu, Yan,
Xu, Shancai,
Ji, Zhiyong,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Chekhonin, Vladimir (2024) and prognosis, as well as targets for the
treatment of glioblastoma.
Methods: This research sought to discover
contributor to global morbidity and mortality. Conventional pharmacological
treatments have been effective
Sufianov, Albert,
Begliarzade, Sema,
Beilerli, Aferin,
Liang, Yanchao,
Ilyasova, Tatiana,
Beylerli, Ozal (2023) and
treatment of lung cancer remains grim, and effective therapeutic targets and molecular markers are urgently